Executive Director, Market Access Strategy (Neurology)
Regeneron Pharmaceuticals
About this role
An Executive Director leading market access strategy for a novel siRNA C5 inhibitor in the Neurology field, focusing on US market access and cross-functional collaboration.
Skills
Qualifications
About Regeneron Pharmaceuticals
regeneron.comDiscover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.
Recent company news
Quadrant Capital Group LLC Purchases 1,564 Shares of Regeneron Pharmaceuticals, Inc. $REGN
4 hours ago
In 2036, Investors Will Regret Not Loading Up on This Multibagger in the Making
6 hours ago
Will Positive Obesity Data and Dupixent Expansion Efforts Change Regeneron Pharmaceuticals' (REGN) Narrative?
1 day ago
Regeneron: Fairly Valued Now After A Stellar Upswing (NASDAQ:REGN)
1 day ago
Capital Research Global Investors Raises Stake in Regeneron Pharmaceuticals, Inc. $REGN
7 hours ago
About Regeneron Pharmaceuticals
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Regeneron Pharmaceuticals.
Salary
$255k – $425k
per year
More jobs at Regeneron Pharmaceuticals
Similar Jobs
Executive Director, Market Access
allogene
Executive Director, Market Access Strategy
Sobi
Director, Market Access Strategy and Insights - HIV Prevention
Gilead Sciences
Senior Director, Market Access Payer and Contract Strategy
Compass Pathways
Associate Director, US HCP Marketing, gMG, Neurology
AstraZeneca
Director, Access Strategy & Innovation, Obesity
Amgen